Shandong Weigao Group Med... (SHWGF)

PNK: SHWGF · Real-Time Price · USD

0.76

0.10 (14.98%)

At close: May 01, 2025, 8:00 PM

Shandong Weigao Medical Polymer Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	6.99B	6.86B	6.63B	5.51B	4.24B	3.81B	3.78B	4.07B
Short-Term Investments	344.58M	495.34M	429.75M	469.61M	421.88M	349.53M	n/a	-638.56M
Long-Term Investments	1.9B	1.36B	990.85M	861.72M	1.04B	728.55M	1.02B	846.68M
Other Long-Term Assets	1.07B	913.86M	1.3B	992.56M	1.36B	1.72B	2.02B	41.2M
Receivables	8.01B	5.74B	5.19B	5.1B	4.34B	3.91B	3.56B	3.34B
Inventory	2.5B	2.32B	1.73B	1.5B	1.24B	1.14B	804.61M	915.59M
Other Current Assets	797.94M	2.68B	6.91B	6.31B	6.44B	5.26B	4.33B	3.59B
Total Current Assets	18.63B	18.09B	16.11B	14.13B	12.6B	10.72B	9.06B	8.68B
Property-Plant & Equipment	7.01B	7.31B	6.66B	6.07B	5.55B	4.61B	3.98B	5.41B
Goodwill & Intangibles	5.06B	5.36B	5.15B	5.16B	5.67B	6.14B	649.88M	714.34M
Total Long-Term Assets	15.04B	15.11B	14.25B	13.22B	13.73B	13.27B	7.73B	7.07B
Total Assets	33.67B	33.2B	30.37B	27.34B	26.33B	23.99B	16.78B	15.76B
Account Payables	4.32B	1.8B	1.7B	1.85B	1.23B	1.04B	713.7M	837.9M
Deferred Revenue	n/a	n/a	2.74B	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	2.55B	960.81M	601.33M	297.89M	1.06B	245.16M	201.22M	400.81M
Other Current Liabilities	448.96M	334.57M	328.38M	251.34M	94.74M	102.14M	74.55M	99.74M
Total Current Liabilities	7.58B	5.93B	5.11B	4.5B	4.55B	3.33B	2.3B	2.68B
Long-Term Debt	1.5B	3.4B	3.46B	3.99B	4.43B	5.09B	804.27M	791.8M
Other Long-Term Liabilities	499.5M	37M	522.85M	101.97M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.1B	3.81B	4.35B	4.45B	4.78B	5.47B	839.1M	867.12M
Total Liabilities	9.68B	9.75B	9.46B	8.95B	9.33B	8.8B	3.14B	3.55B
Total Debt	4.17B	4.49B	4.14B	4.32B	5.52B	5.34B	1.01B	1.19B
Common Stock	457.06M	457.06M	457.06M	452.23M	452.23M	452.23M	452.23M	452.23M
Retained Earnings	18.63B	17.31B	15.44B	13.72B	12.15B	10.84B	9.8B	8.21B
Comprehensive Income	n/a	981.86M	762.56M	1.29B	1B	644.19M	511.8M	-1.35B
Shareholders Equity	22.45B	21.67B	19.27B	17.55B	16.19B	14.51B	13.34B	11.87B
Total Investments	1.9B	1.85B	1.42B	1.33B	1.47B	1.08B	1.02B	208.12M